시장보고서
상품코드
1532896

재조합 세포배양 보충제 시장 : 유형별, 용도별, 최종사용자별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

Recombinant Cell Culture Supplements Market, By Type, By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

발행일: | 리서치사: AnalystView Market Insights | 페이지 정보: 영문 284 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

재조합 세포배양 보충제 시장 규모는 2023년 27억 232만 달러로 2024년부터 2032년까지 CAGR 7.39%로 확대될 것

재조합 세포배양 보충제 시장 - 시장 역학

바이오의약품 및 줄기세포 치료 연구 수요 확대가 시장 수요를 촉진할 것으로 전망

바이오의약품 부문은 단클론항체, 백신, 세포 치료제 등 생물학적 제제 개발에 힘입어 지속적으로 성장하고 있습니다. 재조합 세포배양 보충제는 대규모 세포배양 시스템에서 이러한 생물학적 제제를 생산하는 데 필수적입니다. 따라서 바이오 제약 산업에서 세포배양 보충제에 대한 높은 수요가 시장 성장을 촉진할 것으로 예상됩니다. 관류 시스템, 일회용 바이오리액터, 마이크로캐리어 기반 배양과 같은 세포배양 기술의 혁신은 세포의 증식과 생산성을 최적화하기 위해 재조합 보충제를 정확하게 배합한 특수 배지 제제를 필요로 합니다.

또한, 재생의료 및 줄기세포 치료 분야는 빠르게 성장하고 있으며, 줄기세포의 증식과 분화를 지원하는 첨단 세포배양 시스템에 대한 수요를 주도하고 있습니다. 재조합 보충제는 이러한 분야에 필요한 성장인자와 사이토카인을 공급하는 데 중요한 역할을 하고 있습니다. 암, 당뇨병, 자가면역질환과 같은 만성질환의 유병률은 전 세계적으로 증가하고 있으며, 제약회사들은 새로운 치료법을 개발하기 위해 노력하고 있습니다. 재조합 세포배양 보충제는 이러한 치료에 사용되는 생물학적 제제 생산에 필수적이며 시장 성장을 주도하고 있습니다.

재조합 세포배양 보충제 시장 - 주요 인사이트

당사의 리서치 애널리스트가 공유한 분석에 따르면, 세계 시장은 예측 기간(2024-2032) 동안 매년 약 7.39%의 CAGR로 성장할 것으로 예상됩니다.

유형별 세분화에 따르면, 재조합 알부민 부문은 만성 질환의 유병률 증가로 인해 2023년에 가장 큰 시장 점유율을 차지할 것으로 예측되었습니다.

용도별로는 세포배양 기술의 발전으로 줄기세포 및 재생의료 분야가 2023년 주요 용도로 꼽혔습니다.

최종사용자 세분화를 기준으로 볼 때, 제약 및 생명공학 기업 부문은 2023년 제약 및 생명공학 기업 부문에서 새로운 세포 기반 치료법의 증가로 인해 최종사용자 중 가장 큰 비중을 차지했습니다.

지역별로는 북미가 2023년 주요 수익원이었습니다.

재조합 세포배양 보충제 시장 - 세분화 분석:

재조합 세포배양 보충제 세계 시장은 유형, 용도, 최종사용자 및 지역에 따라 세분화됩니다.

재조합 알부민, 재조합 인슐린, 재조합 트랜스페린, 기타. 재조합 알부민 부문이 시장을 주도하고 있습니다. 만성 질환과 암 질환의 유병률 증가가 시장 성장을 주도하고 있습니다.

시장은 용도별로 줄기세포-재생의료, 바이오 생산, 기타 세 가지로 분류됩니다. 줄기세포 및 재생의료 분야가 시장을 주도하고 있습니다. 세포 치료 및 재생의료 분야의 개발 확대가 이 부문의 성장을 주도하고 있습니다.

시장은 최종사용자별로 제약 및 바이오 기업, 연구기관, 기타 세 가지로 분류됩니다. 제약 및 바이오 기업이 시장을 독점하고 있으며, 예측 기간 동안 높은 우위를 유지할 것으로 보입니다. 생명공학 기업들은 새로운 세포 치료제를 개발하기 위해 정부로부터 많은 자금을 지원받으며 시장에서 경쟁력을 유지하고 있습니다.

재조합 세포배양 보충제 시장 - 지리적 인사이트

지리적으로 이 시장은 북미, 라틴아메리카, 유럽, 아시아태평양, 중동 및 아프리카에 분포되어 있습니다. 북미, 특히 미국은 재조합 세포배양 보충제 세계 시장에서 지배적인 위치를 차지하고 있습니다. 엄격한 규제 프레임워크와 가이드라인이 세포배양 배지 제제에서 동물성 성분을 함유하지 않은 고품질 보충제에 대한 수요를 촉진하고 있습니다. 한편, 유럽 시장에서는 바이오 제조의 일관성, 안전성 및 규제 준수를 보장하기 위해 유전자재조합 보충제의 사용이 강조되고 있습니다.

재조합 세포배양 보충제 시장 - 경쟁 상황:

재조합 세포배양 보충제 시장은 새로운 세포 치료제 혁신을 위해 지속적으로 노력하는 여러 주요 기업들이 치열한 경쟁을 벌이고 있습니다. 시장 진입 기업들은 전문 지식을 활용하고 시장 도달 범위를 확대하기 위해 학계, 생명공학 기업, 제약사와의 제휴 및 공동 연구를 적극적으로 추진하고 있습니다. 또한, 바이오의약품 제조 활동의 확대에 대응하기 위해 기업들은 특히 아시아태평양 및 라틴아메리카 등 신흥 시장에서 지리적 입지를 확장하고 있습니다.

목차

제1장 재조합 세포배양 보충제 시장 개요

  • 조사 범위
  • 시장 추정 연도

제2장 주요 요약

  • 시장 내역
  • 경쟁 인사이트

제3장 재조합 세포배양 보충제의 주요 시장 동향

  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회
  • 시장 전망 동향

제4장 재조합 세포배양 보충제 산업 연구

  • PEST 분석
  • Porter's Five Forces 분석
  • 성장 전망 매핑
  • 규제 프레임워크 분석

제5장 재조합 세포배양 보충제 시장 : COVID-19의 영향 분석

  • COVID-19 이전의 영향 분석
  • COVID-19 이후의 영향 분석

제6장 재조합 세포배양 보충제 시장 상황

  • 재조합 세포배양 보충제 시장 점유율 분석, 2023년
  • 주요 제조업체별 내역 데이터
    • 기존 기업 분석
    • 신흥 기업 분석

제7장 재조합 세포배양 보충제 시장 - 유형별

  • 개요
    • 부문 점유율 분석(유형별)
    • 재조합 알부민
    • 재조합 인슐린
    • 재조합 트랜스페린
    • 기타

제8장 재조합 세포배양 보충제 시장 - 용도별

  • 개요
    • 용도별 부문 점유율 분석
    • 줄기세포와 재생의료
    • 바이오 프로덕션
    • 기타

제9장 재조합 세포배양 보충제 시장 - 최종사용자별

  • 개요
    • 최종사용자별 부문 점유율 분석
    • 제약·바이오테크놀러지 기업
    • 연구기관
    • 기타

제10장 재조합 세포배양 보충제 시장 - 지역별

  • 소개
  • 북미
    • 개요
    • 북미의 주요 제조업체
    • 미국
    • 캐나다
  • 유럽
    • 개요
    • 유럽의 주요 제조업체
    • 독일
    • 이탈리아
    • 영국
    • 프랑스
    • 러시아
    • 네덜란드
    • 스웨덴
    • 폴란드
    • 기타
  • 아시아태평양(APAC)
    • 개요
    • 아시아태평양의 주요 제조업체
    • 인도
    • 중국
    • 일본
    • 한국
    • 호주
    • 태국
    • 인도네시아
    • 필리핀
    • 기타
  • 라틴아메리카
    • 개요
    • 라틴아메리카의 주요 제조업체
    • 브라질
    • 멕시코
    • 아르헨티나
    • 콜롬비아
    • 기타
  • 중동 및 아프리카
    • 개요
    • 중동 및 아프리카의 주요 제조업체
    • 사우디아라비아
    • 아랍에미리트
    • 이스라엘
    • 터키
    • 알제리
    • 이집트
    • 기타

제11장 주요 벤더 분석 - 재조합 세포배양 보충제 업계

  • 경쟁 대시보드
  • 기업 개요
    • Thermo Fisher Scientific
    • Merck KGaA
    • Lonza Group
    • GE Healthcare Life Sciences
    • STEMCELL Technologies
    • Corning Life Sciences
    • BD Biosciences
    • Fujifilm Irvine Scientific
    • Sartorius AG
    • Bio-Techne Corporation
    • PeproTech
    • Biological Industries
    • Gibco
    • CellGenix
    • Repligen Corporation
    • Others

제12장 애널리스트의 전방위 전망

ksm 24.09.03

REPORT HIGHLIGHT

Recombinant Cell Culture Supplements Market size was valued at USD 2,702.32 Million in 2023, expanding at a CAGR of 7.39% from 2024 to 2032.

Recombinant cell culture supplements are added to cell culture media to support the growth, viability, and productivity of cells in vitro application. These supplements are typically derived from recombinant sources, meaning they are produced using genetic engineering techniques in host organisms like bacteria, yeast, or mammalian cells.

Recombinant Cell Culture Supplements Market- Market Dynamics

Growing demand from biopharmaceuticals and research in stem therapies are expected to propel market demand

The biopharmaceutical sector continues to expand, driven by the development of biologics such as monoclonal antibodies, vaccines, and cell therapies. Recombinant cell culture supplements are essential to produce these biologics in large-scale cell culture systems. Thus, high demand for cell culture supplements from the biopharmaceutical industry is projected to bolster market growth. Technological innovations in cell culture techniques, such as perfusion systems, single-use bioreactors, and microcarrier-based cultures, require specialized media formulations with precise compositions of recombinant supplements to optimize cell growth and productivity.

Further, the field of regenerative medicine and stem cell therapies is expanding rapidly, driving the demand for advanced cell culture systems that support the growth and differentiation of stem cells. Recombinant supplements play a critical role in providing the necessary growth factors and cytokines for these applications. The prevalence of chronic diseases such as cancer, diabetes, and autoimmune disorders is rising globally, prompting pharmaceutical companies to develop new therapies. Recombinant cell culture supplements are essential to produce biologics used in these therapies, driving market growth.

Recombinant Cell Culture Supplements Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 7.39% over the forecast period (2024-2032)

Based on Type segmentation, recombinant albumin segment was predicted to show maximum market share in the year 2023, owing to growing prevalence of chronic diseases.

Based on Application segmentation, the stem cell & regenerative medicine segment was the leading Application in 2023, due to rising advancements in cell culture technology.

Based on End User segmentation, pharmaceutical & biotech companies' segment was the leading End User in 2023, owing to increasing number of novel cell-based therapies in biotech companies.

On the basis of region, North America was the leading revenue generator in 2023, owing to rising government funding in cell technology.

Recombinant Cell Culture Supplements Market- Segmentation Analysis:

The Global Recombinant Cell Culture Supplements Market is segmented on the basis of Type, Application, End User, and Region.

The market is divided into four categories based on Type: recombinant albumin, recombinant insulin, recombinant transferrin, and others. The recombinant albumin segment dominates the market. The growing prevalence of chronic and cancer disorders is boosting market growth.

The market is divided into three categories based on Application: stem cell & regenerative medicine, bioproduction, and others. The stem cell & regenerative medicine segment dominates the market. Growing developments in cell therapies and regenerative medicine are mainly spurring segment growth.

The market is divided into three categories based on End User: pharmaceutical & biotech companies, research institutes, and others. The pharmaceutical & biotech companies segment dominates the market and is expected to maintain its high dominance during the forecast period. Biotech companies attract significant government funding to advance novel cell therapies to remain competent in the market.

Recombinant Cell Culture Supplements Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America, specifically the United States, holds a dominant position in the global market for recombinant cell culture supplements. Stringent regulatory frameworks and guidelines drive the demand for high-quality, animal component-free supplements in cell culture media formulations. On the other side, European markets emphasize the use of recombinant supplements to ensure consistency, safety, and regulatory compliance in biomanufacturing.

Recombinant Cell Culture Supplements Market- Competitive Landscape:

The Recombinant Cell Culture Supplements market is characterized by intense competition among several key players who are continuously striving to innovate new cell therapies. Market players indulge in partnerships, collaborations with academic institutions, biotech companies, and pharmaceutical firms are common to leverage expertise and expand market reach. Further, companies are expanding their geographical presence, particularly in emerging markets like Asia-Pacific and Latin America, to capitalize on growing biopharmaceutical manufacturing activities.

Recent Developments:

In 2023, Lonza, a prominent supplier of cell culture solutions, has partnered with Sartorius, a leading provider of equipment and services for the biopharmaceutical industry.

In 2023, Thermo Fisher Scientific Inc. has collaborated with Cell and Gene Therapy Catapult, an innovation center in the UK focused on advancing cell and gene therapies.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET KEY PLAYERS

  • Thermo Fisher Scientific
  • Merck KGaA
  • Lonza Group
  • GE Healthcare Life Sciences
  • STEMCELL Technologies
  • Corning Life Sciences
  • BD Biosciences
  • Fujifilm Irvine Scientific
  • Sartorius AG
  • Bio-Techne Corporation
  • PeproTech
  • Biological Industries
  • Gibco
  • CellGenix
  • Repligen Corporation
  • Others

GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET, BY TYPE- MARKET ANALYSIS, 2019-2032

  • Recombinant albumin
  • Recombinant insulin
  • Recombinant transferrin
  • Others

GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019-2032

  • Stem cell & regenerative medicine
  • Bioproduction
  • Others

GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET, BY END USER- MARKET ANALYSIS, 2019-2032

  • Pharmaceutical & biotech companies
  • Research institutes
  • Others

GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Recombinant Cell Culture Supplements Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Recombinant Cell Culture Supplements Market Snippet by Type
    • 2.1.2. Recombinant Cell Culture Supplements Market Snippet by Application
    • 2.1.3. Recombinant Cell Culture Supplements Market Snippet by End User
    • 2.1.4. Recombinant Cell Culture Supplements Market Snippet by Country
    • 2.1.5. Recombinant Cell Culture Supplements Market Snippet by Region
  • 2.2. Competitive Insights

3. Recombinant Cell Culture Supplements Key Market Trends

  • 3.1. Recombinant Cell Culture Supplements Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Recombinant Cell Culture Supplements Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Recombinant Cell Culture Supplements Market Opportunities
  • 3.4. Recombinant Cell Culture Supplements Market Future Trends

4. Recombinant Cell Culture Supplements Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Recombinant Cell Culture Supplements Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Recombinant Cell Culture Supplements Market Landscape

  • 6.1. Recombinant Cell Culture Supplements Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Recombinant Cell Culture Supplements Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2024 & 2032 (%)
    • 7.1.2. Recombinant albumin
    • 7.1.3. Recombinant insulin
    • 7.1.4. Recombinant transferrin
    • 7.1.5. Others

8. Recombinant Cell Culture Supplements Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 8.1.2. Stem cell & regenerative medicine
    • 8.1.3. Bioproduction
    • 8.1.4. Others

9. Recombinant Cell Culture Supplements Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 9.1.2. Pharmaceutical & biotech companies
    • 9.1.3. Research institutes
    • 9.1.4. Others

10. Recombinant Cell Culture Supplements Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Recombinant Cell Culture Supplements Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Recombinant Cell Culture Supplements Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Recombinant Cell Culture Supplements Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Recombinant Cell Culture Supplements Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Recombinant Cell Culture Supplements Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Recombinant Cell Culture Supplements Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Thermo Fisher Scientific
    • 11.2.2. Merck KGaA
    • 11.2.3. Lonza Group
    • 11.2.4. GE Healthcare Life Sciences
    • 11.2.5. STEMCELL Technologies
    • 11.2.6. Corning Life Sciences
    • 11.2.7. BD Biosciences
    • 11.2.8. Fujifilm Irvine Scientific
    • 11.2.9. Sartorius AG
    • 11.2.10. Bio-Techne Corporation
    • 11.2.11. PeproTech
    • 11.2.12. Biological Industries
    • 11.2.13. Gibco
    • 11.2.14. CellGenix
    • 11.2.15. Repligen Corporation
    • 11.2.16. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제